PTEN status in advanced colorectal cancer treated with cetuximab

Francesca Negri(University of Parma), Andrea Ardizzoni(University of Bologna)

British Journal of Cancer

December 1, 2009

10.1038/sj.bjc.6605471

Cited by 85

Related Papers

Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

|JNCI Journal of the National Cancer Institute|2007|606

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

|Molecular Cancer|2012|45

Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer

|Cancers|2020|42

Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism

|Oncotarget|2017|35

High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer

|Oncology Reports|2019|13